“…(TLR)-induced proinflammatory mediators (Park et al, 2004;Kitamura et al, 2005;Cheng et al, 2008;Melillo et al, 2010;Wölfle et al, 2011); and 5) increased tryptophan-catabolizing enzyme indoleamine 2,3-dioxygenase and resultant T cell apoptosis mediated by kynurenine, a tryptophan metabolite (Barton, 2006). These STAT3 effects are mediated by pY-STAT3; inhibition of JAK/STAT3 signaling improves mature DC function and augments antitumor immunity (Nefedova et al, 2004(Nefedova et al, , 2005a, although attenuating STAT3 and NF-kB signaling in immature DCs leads to systemic DC dysfunction in non-small cell lung cancer (NSCLC) (Li et al, 2017). 4.…”